 Multi-country medical and recreational cannabis operator IM Cannabis CSE:IMCC NASDAQ:IMCC is gearing up to expand its product offering in the German market this year with a range of specially formulated high-THC, balanced-THC and CBD oil extracts. The company announced its German subsidiary, Adjupharm GmbH, signed a two-year supply agreement with MediPharm Labs OTC:MEDIF for the production and delivery of IMC-branded, specially formulated extracts. 